Synthesis and evaluation of analogs of Efavirenz (SUSTIVATM) as HIV-1 reverse transcriptase inhibitors
- 28 October 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (19) , 2805-2810
- https://doi.org/10.1016/s0960-894x(99)00486-2
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1995
- An Assay for HIV RNA in Infected Cell Lysates, and its use for the Rapid Evaluation of Antiviral EfficacyAntiviral Chemistry and Chemotherapy, 1994
- Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogs and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)carbonyl]-4-[3-[(1-methylethyl)amino]pyridinyl]piperazinemonomethanesulfonate (U-90152S), a second-generation clinical candidateJournal of Medicinal Chemistry, 1993
- Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.Journal of Biological Chemistry, 1992
- Insights Into HIV Chemotherapy*AIDS Research and Human Retroviruses, 1992
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990